media – Page 861 – Pharma & Medical Industry Insights Hub | Drugdu Insights & Updates

Ddu Attended the FIME Exhibition–Leading a New Era of Medical Trade

The 27th Florida International Medical Exhibition (FIME) was grandly held in Orlando, USA from August 8th to August 10th, 2017. As the leading global pharmaceutical and medical device B2B online platform, Ddu, attended the exhibition along with products of high priority members, becoming one of the most popular brands at FIME.
- Source: Ddu
- 1,520
- August 16, 2017
AACC Exhibitions & Activities FIME medical device pharmaceutical
MC10 and Shirley Ryan AbilityLab to clinically study BioStampRC System

New treatments for neurodegenerative disease and motion disability will be developed by a research collaboration between digital healthcare solutions provider MC10 and US-based rehabilitation research hospital, Shirley Ryan AbilityLab.
- Source: massdevice
- 954
- August 16, 2017
disability neurodegenerative rehabilitation Researches
VentureMed raises $15m in Series B

Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
- Source: massdevice
- 750
- August 16, 2017
Company Insight Market Views medical device peripheral artery Series
Atlas awarded £2m grant for infectious disease test

In support of the project in adopting Atlas Genetic's io rapid diagnostic platform into UK sexual health clinics, Innovative UK has awarded them a grant of £2 million.
- Source: news.open-medical
- 674
- August 16, 2017
Company Insight diagnostic infectious
New CUHK study shows early nasopharyngeal cancer detection with EBV DNA

Early asymptomatic nasopharyngeal carcinoma (NPC) will possibly be detectable by plasma Epstein-Barr virus (EBV) DNA analysis, according to a new study carried out by the Chinese University of Hong Kong (CUHK).
- Source: medicaldevice-network
- 789
- August 15, 2017
carcinoma MRI nasopharyngeal Researches
NICE turns down kidney cancer drugs

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use.
- Source: pharmatimes
- 748
- August 15, 2017
cancer kidney Market Views NHS renal
FDA approves Renovis Surgical’s 3D-printed posterior lumbar interbody fusion systems

The clearance for 3D-printed Tesera porous titanium interbody fusion systems has been secured from the US Food and Drug Administration (FDA) by Renovis Surgical Technologies.
- Source: orthopedicdevices
- 640
- August 15, 2017
Company Insight FDA interbody lumbar New Approvals
Neuros Medical, Evolent Health, Osprey Medical

Deals are reached by Neuros Medical, Evolent Health and Osprey Medical last week.
- Source: medicaldevice-network
- 786
- August 14, 2017
Clinical R&D Researches
Esophageal surgeries with robotic platforms safe and effective

Transchiatal esophagectomy procedures utilizing robotic platforms are “effective and safe” for carefully selected patients, according to a new study from Allina Health hospitals.
- Source: massdevice
- 647
- August 14, 2017
esophagectomy lymph Researches
£2m UK consortium to tackle gene therapy

A two-year, £2 million project focused on gene and cell therapy manufacturing will be embarked on by Oxford BioMedica, will embark on.
- Source: news.open-medical
- 777
- August 14, 2017
cell Company Insight gene therapy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.